4//SEC Filing
PRENDERGAST FRANKLYN G 4
Accession 0001213900-20-015049
CIK 0001763950other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:33 PM ET
Size
5.6 KB
Accession
0001213900-20-015049
Insider Transaction Report
Form 4
PRENDERGAST FRANKLYN G
Director
Transactions
- Award
Stock Option
2020-06-15+9,135→ 9,135 totalExercise: $15.00→ Common Stock (9,135 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted options to purchase 9,135 shares of the Issuer's common stock at the exercise price equal to the price per share sold in the Issuer's initial public offering ("IPO"). The options granted will vest in equal monthly increments over a 36 month period commencing upon the closing of the Issuer's IPO, which is the grant date of the options. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the grant date.
Documents
Issuer
Lantern Pharma Inc.
CIK 0001763950
Entity typeother
Related Parties
1- filerCIK 0001233256
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 5:33 PM ET
- Size
- 5.6 KB